Mutations in "CDK13" that have been identified in patients with this disorder have mostly been missense mutations (single amino acid changes) that have changed the amino acid structure of the otherwise highly conserved (little-changed) protein kinase domain of the gene, leading to structural changes that affect the operation of this critical protein.